Literature DB >> 2050395

Inhibition of macrophage phagosome-lysosome fusion by Salmonella typhimurium.

N A Buchmeier1, F Heffron.   

Abstract

Salmonella typhimurium-infected macrophages were examined by electron microscopy to determine whether intracellular survival of S. typhimurium is associated with failure of bacteria containing phagosomes to fuse with secondary lysosomes. S. typhimurium 14028 actively inhibited phagosome-lysosome fusion and appeared to preferentially divide within unfused phagocytic vesicles. In comparison with Escherichia coli, S. typhimurium inhibited phagosome-lysosome fusion in peritoneal macrophages, J774 macrophages, and bone marrow-derived macrophages from both BALB/c (itys) and SWR/J (ityr) mice. The mechanism responsible for Salmonella inhibition of phagosome-lysosome fusion is unknown but requires viable salmonellae, is not blocked by opsonization with fresh normal mouse serum, and is not due to lipopolysaccharide. Inhibition of phagosome-lysosome fusion may play a critical role in survival of salmonellae within macrophages and in virulence.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2050395      PMCID: PMC258000          DOI: 10.1128/iai.59.7.2232-2238.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Phagolysosome formation, cyclic adenosine 3':5'-monophosphate and the fate of Salmonella typhimurium within mouse peritoneal macrophages.

Authors:  M E Carrol; P S Jackett; V R Aber; D B Lowrie
Journal:  J Gen Microbiol       Date:  1979-02

2.  Modification of macrophage function.

Authors:  R V Blanden
Journal:  J Reticuloendothel Soc       Date:  1968-06

3.  The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers.

Authors:  J Vieira; J Messing
Journal:  Gene       Date:  1982-10       Impact factor: 3.688

4.  Phagosome-lysosome fusion and cyclic adenosine 3':5'-monophosphate in macrophages infected with Mycobacterium microti, Mycobacterium bovis BCG or Mycobacterium lepraemurium.

Authors:  D B Lowrie; V R Aber; P S Jackett
Journal:  J Gen Microbiol       Date:  1979-02

5.  Prevention of phagosome-lysosome fusion in cultured macrophages by sulfatides of Mycobacterium tuberculosis.

Authors:  M B Goren; P D'Arcy Hart; M R Young; J A Armstrong
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

6.  Interaction of Nocardia asteroides with rabbit alveolar macrophages: association of virulence, viability, ultrastructural damage, and phagosome-lysosome fusion.

Authors:  C Davis-Scibienski; B L Beaman
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

7.  Phagosome-lysosome fusion. Characterization of intracellular membrane fusion in mouse macrophages.

Authors:  M C Kielian; Z A Cohn
Journal:  J Cell Biol       Date:  1980-06       Impact factor: 10.539

8.  Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes.

Authors:  J A Armstrong; P D Hart
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

9.  Trypanosoma cruzi: mechanism of entry and intracellular fate in mammalian cells.

Authors:  N Nogueira; Z Cohn
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

10.  Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival.

Authors:  J A Armstrong; P D Hart
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

View more
  100 in total

1.  A role for Salmonella fimbriae in intraperitoneal infections.

Authors:  R A Edwards; D M Schifferli; S R Maloy
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Potent immunoregulatory effects of Salmonella typhi flagella on antigenic stimulation of human peripheral blood mononuclear cells.

Authors:  T L Wyant; M K Tanner; M B Sztein
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

3.  Cloning and characterization of the first cnidarian ADP-ribosylation factor, and its involvement in the Aiptasia-Symbiodinum endosymbiosis.

Authors:  Ming-Chyuan Chen; Ying-Min Cheng; Li-Hsueh Wang; Chorng-Horng Lin; Xing-Yan Huang; Ming-Chin Liu; Ping-Jyun Sung; Lee-Shing Fang
Journal:  Mar Biotechnol (NY)       Date:  2004-04-19       Impact factor: 3.619

4.  Cell-free fusion of bacteria-containing phagosomes with endocytic compartments.

Authors:  Ulrike Becken; Andreas Jeschke; Katharina Veltman; Albert Haas
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-11       Impact factor: 11.205

Review 5.  Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy.

Authors:  Yvonne Paterson; Patrick D Guirnalda; Laurence M Wood
Journal:  Semin Immunol       Date:  2010-03-17       Impact factor: 11.130

Review 6.  Recombinant avirulent salmonellae as oral vaccine carriers.

Authors:  F Schödel
Journal:  Infection       Date:  1992 Jan-Feb       Impact factor: 3.553

7.  Characterization of phagosome trafficking and identification of PhoP-regulated genes important for survival of Yersinia pestis in macrophages.

Authors:  Jens P Grabenstein; Hana S Fukuto; Lance E Palmer; James B Bliska
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 8.  Manipulation of rab GTPase function by intracellular bacterial pathogens.

Authors:  John H Brumell; Marci A Scidmore
Journal:  Microbiol Mol Biol Rev       Date:  2007-12       Impact factor: 11.056

9.  Quantitative PCR-based competitive index for high-throughput screening of Salmonella virulence factors.

Authors:  Hyunjin Yoon; Phillipe Gros; Fred Heffron
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

10.  Differential Immune Phenotypes in Human Monocytes Induced by Non-Host-Adapted Salmonella enterica Serovar Choleraesuis and Host-Adapted S. Typhimurium.

Authors:  Hiba Ibrahim; Basim Askar; Scott Hulme; Peter Neilson; Paul Barrow; Neil Foster
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.